Literature DB >> 11572033

Adrenal cortical carcinoma.

A P Dackiw1, J E Lee, R F Gagel, D B Evans.   

Abstract

Adrenal cortical carcinoma is a rare endocrine tumor for which complete surgical resection is the only potentially curative treatment. Accurate preoperative evaluation (biochemical and radiographic) of the patient who presents with an adrenal mass maximizes the opportunity for the patient to undergo a complete, margin-negative resection of the primary tumor, which is the most powerful prognostic variable for long-term survival. The response to chemotherapy or mitotane is modest in patients with advanced disease. Hopefully, an improved understanding of the molecular pathogenesis of this challenging tumor will lead to the development of more effective therapies in the future.

Entities:  

Mesh:

Year:  2001        PMID: 11572033     DOI: 10.1007/s00268-001-0030-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  99 in total

Review 1.  The adrenal incidentaloma: guidelines for evaluation and recommendations for management.

Authors:  D J Graham; C R McHenry
Journal:  Surg Oncol Clin N Am       Date:  1998-10       Impact factor: 3.495

2.  MEN1 gene mutation analysis of sporadic adrenocortical lesions.

Authors:  B Görtz; J Roth; E J Speel; A Krähenmann; R R De Krijger; X Matias-Guiu; S Muletta-Feurer; K Rütmann; P Saremaslani; P U Heitz; P Komminoth
Journal:  Int J Cancer       Date:  1999-01-29       Impact factor: 7.396

3.  Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up.

Authors:  A Khorram-Manesh; H Ahlman; S Jansson; B Wängberg; O Nilsson; C E Jakobsson; B Eliasson; S Lindstedt; L E Tisell
Journal:  World J Surg       Date:  1998-06       Impact factor: 3.352

4.  5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.

Authors:  M Schlumberger; L Brugieres; C Gicquel; J P Travagli; J P Droz; C Parmentier
Journal:  Cancer       Date:  1991-06-15       Impact factor: 6.860

5.  Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis.

Authors:  M Reincke; P Mora; F Beuschlein; W Arlt; G P Chrousos; B Allolio
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

6.  An eleven-year experience with adrenocortical carcinoma.

Authors:  R F Pommier; M F Brennan
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

7.  p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies.

Authors:  M Reincke; M Karl; W H Travis; G Mastorakos; B Allolio; H M Linehan; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

Review 8.  Magnetic resonance imaging of the adrenal gland.

Authors:  G W Boland; M J Lee
Journal:  Crit Rev Diagn Imaging       Date:  1995

9.  Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.

Authors:  J P Luton; S Cerdas; L Billaud; G Thomas; B Guilhaume; X Bertagna; M H Laudat; A Louvel; Y Chapuis; P Blondeau
Journal:  N Engl J Med       Date:  1990-04-26       Impact factor: 91.245

10.  Incidentally discovered adrenal tumors: an institutional perspective.

Authors:  M F Herrera; C S Grant; J A van Heerden; P F Sheedy; D M Ilstrup
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

View more
  75 in total

Review 1.  Management of adjuvant mitotane therapy following resection of adrenal cancer.

Authors:  M Terzolo; A Ardito; B Zaggia; F Laino; A Germano; S De Francia; F Daffara; A Berruti
Journal:  Endocrine       Date:  2012-06-17       Impact factor: 3.633

2.  [¹⁸F]Fluorodeoxyglucose positron emission tomography-guided therapy in metastatic adrenocortical carcinoma: an illustrative case.

Authors:  Hubert H Chuang; Ferhat Deniz; Kanishka Sircar; Camilo Jimenez; Carlos Rubin De Celis; Christopher G Wood; Mouhammed Amir Habra
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

Review 3.  Multi-organ resection for locally advanced adrenocortical cancer: surgical strategy and literature review.

Authors:  F Guida; M Clemente; L Valvano; C Napolitano
Journal:  G Chir       Date:  2015 Sep-Oct

4.  Identification of Niclosamide as a Novel Anticancer Agent for Adrenocortical Carcinoma.

Authors:  Kei Satoh; Lisa Zhang; Yaqin Zhang; Raju Chelluri; Myriem Boufraqech; Naris Nilubol; Dhaval Patel; Min Shen; Electron Kebebew
Journal:  Clin Cancer Res       Date:  2016-02-12       Impact factor: 12.531

5.  Adrenocortical carcinoma: effect of hospital volume on patient outcome.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Marco Boniardi; Giorgio De Toma; Luigi Antonio Marzano; Paolo Miccoli; Francesco Minni; Mario Morino; Maria Rosa Pelizzo; Andrea Pietrabissa; Andrea Renda; Andrea Valeri; Carmela De Crea; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2011-11-09       Impact factor: 3.445

6.  Long-term outcome following laparoscopic adrenalectomy for large solid adrenal cortex tumors.

Authors:  F Fausto Palazzo; Frederic Sebag; Mauricio Sierra; Giuseppe Ippolito; Philippe Souteyrand; Jean-François Henry
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

7.  Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?

Authors:  C Pohlink; A Tannapfe; U Eichfeld; F Schmidt; D Führer; R Paschke; C A Koch
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 8.  Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.

Authors:  Irina Veytsman; Lynnette Nieman; Tito Fojo
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

9.  Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.

Authors:  Neda Amini; Georgios Antonios Margonis; Yuhree Kim; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2015-08-18       Impact factor: 5.344

10.  Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.

Authors:  Liem M Phan; Enrique Fuentes-Mattei; Weixin Wu; Guermarie Velazquez-Torres; Kanishka Sircar; Christopher G Wood; Tao Hai; Camilo Jimenez; Gilbert J Cote; Levent Ozsari; Marie-Claude Hofmann; Siyuan Zheng; Roeland Verhaak; Lance Pagliaro; Maria Angelica Cortez; Mong-Hong Lee; Sai-Ching J Yeung; Mouhammed Amir Habra
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.